UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

418 Inhibition of IGF1R with Ganitumab Switches Pancreatic Cancer Cells to Oxidative Metabolism

European journal of cancer (1990), 2012-11, Vol.48, p.127-127

2012

Volltextzugriff (PDF)

Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b

Oncogene, 1997-01, Vol.14 (1), p.1-16

1997

Volltextzugriff (PDF)

HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells

Breast cancer research : BCR, 2005-01, Vol.7 (6), p.R1058-R1079, Article R1058

2005

Volltextzugriff (PDF)

509 POSTER Efficacy of AMG 479, a fully human anti-IGF-1R monoclonal antibody, against xenograft models displaying genetic alterations in Ras/Raf, PI3K/PTEN and p53 pathways

European journal of cancer supplements, 2008, Vol.6 (12), p.162-162

2008

Volltextzugriff (PDF)

Lymphocytic subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis

The Journal of heart and lung transplantation, 1992-05, Vol.11 (3 Pt 1), p.458-466

1992

Volltextzugriff (PDF)

Effect of AMG 479 on anti-tumor effects of gemcitabine and erlotinib against pancreatic carcinoma xenograft models

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.4617-4617

2008

Volltextzugriff (PDF)

Psychoneuroimmunology in oral biology and medicine: the model of oral lichen planus

Annals of the New York Academy of Sciences, 2002-06, Vol.966 (1), p.429-440

2002

Volltextzugriff (PDF)

Brequinar sodium : monitoring immunosuppressive activity

Transplantation proceedings, 1993-06, Vol.25 (3), p.32-36

1993

Volltextzugriff (PDF)

Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1- Delta 11b

Oncogene, 1997-01, Vol.14 (1), p.1-16

1997

Volltextzugriff (PDF)

FK 506 inhibits the development of transplant arteriosclerosis

Transplantation proceedings, 1991-12, Vol.23 (6), p.3272-3274

1991

Volltextzugriff (PDF)

A comparison of lymphocytic subsets participating in concordant cardiac xenograft and acute cardiac allograft rejection

Transplantation proceedings, 1992-04, Vol.24 (2), p.533-534

1992

Volltextzugriff (PDF)

Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection

Transplantation proceedings, 1993-06, Vol.25 (3), p.57-58

1993

Volltextzugriff (PDF)

205 POSTER AMG 479, a fully human anti IGF-1 receptor monoclonal antibody, enhances the response of established colon and pancreatic xenografts to chemotherapeutic agents

European journal of cancer supplements, 2006-11, Vol.4 (12), p.64-64

2006

Volltextzugriff (PDF)

Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium

Transplantation proceedings, 1993-02, Vol.25 (1), p.708-709

1993

Volltextzugriff (PDF)

Use of brequinar sodium for preventing cardiac allograft rejection in primates

Transplantation proceedings, 1993-06, Vol.25 (3), p.48-53

1993

Volltextzugriff (PDF)

Individual and species differences in the in vitro sensitivity to brequinar sodium

Transplantation proceedings, 1993-06, Vol.25 (3), p.61-64

1993

Volltextzugriff (PDF)

Differential usage of the T cell receptor repertoire for allorecognition of heart, liver, and kidney grafts

Transplantation, 1995-06, Vol.59 (12), p.1709

1995

Volltextzugriff (PDF)

Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b

Oncogene, 1997-01, Vol.14 (1), p.1

1997

Volltextzugriff (PDF)

The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat

Transplantation, 1993-09, Vol.56 (3), p.667

1993

Volltextzugriff (PDF)

Differences in individual and species lymphocyte responsiveness to the immunosuppressive effects of brequinar sodium

Human immunology, 1992, Vol.34 (1), p.78-78

1992

Volltextzugriff (PDF)

The in vitro difference in species sensitivity to BQR inhibition of the allogeneic and xenogeneic MLR

Human immunology, 1991-10, Vol.32, p.22-22

1991

Volltextzugriff (PDF)

Abstract 2180: AMG 176 exhibits robust antitumor activity in combination with standard of care agents in models of acute myeloid leukemia

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2180-2180

2019

Volltextzugriff (PDF)

MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor

Oncotarget, 2017-03, Vol.8 (11), p.17795-17809

2017

Volltextzugriff (PDF)

Ganitumab (AMG 479) Inhibits IGF-II-Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy

Clinical cancer research, 2014-06, Vol.20 (11), p.2947-2958

2014

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Biological And Medical Sciences
(18)
Medical Sciences
(17)
Humans
(15)
Animals
(13)
Surgery
(9)
Female
(8)
Heart Transplantation - Immunology
(8)
Male
(8)
Rats
(8)
Rats, Inbred Lew
(8)
Transplantation
(8)
Immunology
(7)
Pharmacology. Drug Treatments
(7)
Immunomodulators
(6)
Oncology
(6)
Pathology
(6)
Biphenyl Compounds - Therapeutic Use
(5)
Biopsy, Needle
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

418 Inhibition of IGF1R with Ganitumab Switches Pancreatic Cancer Cells to Oxidative Metabolism

Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b

HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells

509 POSTER Efficacy of AMG 479, a fully human anti-IGF-1R monoclonal antibody, against xenograft models displaying genetic alterations in Ras/Raf, PI3K/PTEN and p53 pathways

Lymphocytic subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis

Effect of AMG 479 on anti-tumor effects of gemcitabine and erlotinib against pancreatic carcinoma xenograft models

Psychoneuroimmunology in oral biology and medicine: the model of oral lichen planus

Brequinar sodium : monitoring immunosuppressive activity

Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1- Delta 11b

FK 506 inhibits the development of transplant arteriosclerosis

A comparison of lymphocytic subsets participating in concordant cardiac xenograft and acute cardiac allograft rejection

Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection

205 POSTER AMG 479, a fully human anti IGF-1 receptor monoclonal antibody, enhances the response of established colon and pancreatic xenografts to chemotherapeutic agents

Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium

Use of brequinar sodium for preventing cardiac allograft rejection in primates

Individual and species differences in the in vitro sensitivity to brequinar sodium

Differential usage of the T cell receptor repertoire for allorecognition of heart, liver, and kidney grafts

Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b

The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat

Differences in individual and species lymphocyte responsiveness to the immunosuppressive effects of brequinar sodium

The in vitro difference in species sensitivity to BQR inhibition of the allogeneic and xenogeneic MLR

AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies

Abstract 2180: AMG 176 exhibits robust antitumor activity in combination with standard of care agents in models of acute myeloid leukemia

MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor

Ganitumab (AMG 479) Inhibits IGF-II-Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy

Suchergebnisse filtern